STipe Therapeutics (private company)

See something wrong or missing? Let us know
Offices:
Aarhus
Business model:
B2B
Investors:
we tracked 3 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

STipe Therapeutics is a biotechnology company with a vision to become a leader in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer.

Companies with similar profile to STipe Therapeutics:

CompanyCriteria
Denmark Galecto Biotech
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden OxThera
66%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Forendo Pharma
66%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Orphazyme
65%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark MinervaX
56%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Denmark Acarix
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Snipr Biome
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Wellington Partners
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
54%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Aprea Therapeutics
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Iceland Alvotech
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Asarina Pharma
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark AFYX Therapeutics
54%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Mobidiag
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Unibio
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
54%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway Oncoinvent
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark InProTher
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Novo A/S
Finland TILT Biotherapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Norway Vaccibody
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Optomed
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes